Carvana Shares Plunge Nearly 10% Despite Strong Headline Earnings
Carvana shares are down almost 10% this morning even as the online used-car retailer delivered another quarter of impressive looking headline results, highlighting growing skepticism that its financial rebound may be outpacing the realities of a shaky auto market.
Revenue jumped to $5.65 billion from $3.66 billion a year earlier, powered by a 44% increase in retail units sold to 155,941, according to Bloomberg. Net income rose to $263 million, or $1.03 per share, compared with $148 million, or 64 cents, a year ago. Adjusted earnings hit $1.50 per share, well ahead of expectations, while adjusted EBITDA climbed to $637 million. The company projected fourth-quarter retail unit sales above 150,000 vehicles.
CEO Ernie Garcia celebrated the scale of the recovery, telling shareholders: “Not only is this growth happening at the same time we are producing margins higher than have ever been reported by any other automotive retailer, but it is also happening at a very significant scale.”
It’s a claim the market now seems to be skeptical of.
Beneath that demand, the auto sector is showing cracks. A major parts supplier (First Brands) and a subprime auto lender (Tricolor) recently failed, while delinquencies on auto loans — particularly among younger buyers — are rising fast. Auto loan delinquencies in 2025 have surged to historic levels, driven by higher vehicle prices, interest rates, and overall affordability issues for consumers.
Analysts warn that lower-income consumers are under growing strain. “There has been nothing but bad news recently on the auto sector when it comes to the low-end consumer,” Matt Maley, chief market strategist at Miller Tabak, told Bloomberg
Carvana’s soaring valuation has also drawn scrutiny. The stock has jumped 78% this year and trades at roughly 53 times earnings, a multiple more in line with Silicon Valley high-flyers than with traditional auto dealers. That leaves little room for disappointment. “Any stumble in guidance, and momentum traders could hit reverse just as fast as they hit the gas,” said Dave Mazza, chief executive of Roundhill Financial.
On top of that, short sellers have accused the company in recent years of aggressive accounting, cutting corners on title transfers, and relying on financing practices that could backfire in a downturn. While the company has denied wrongdoing and tightened procedures, critics argue the rapid expansion masked deeper structural risks.
Other controversy has followed Carvana since its pandemic-era surge. After becoming a meme-stock favorite, shares crashed 98% in 2022 when losses mounted and debt worries ballooned. The current rebound has been fueled by cost-cutting, slower inventory growth, and a massive debt restructuring — moves that bought time but did not erase long-term questions about sustainability.
Meanwhile, the company’s CEO and his father have sold billions of dollars in Carvana stock.
The company’s pitch is that online scale and logistics efficiency can eventually outclass brick-and-mortar rivals such as CarMax and Lithia Motors. Yet critics argue the business remains capital-intensive — requiring costly facilities, fleets, and reconditioning centers — despite its tech-driven image. As Karobaar Capital’s Haris Khurshid put it: “It’s basically a capital intensive retailer wearing a tech premium.”
Tyler Durden Thu, 10/30/2025 – 09:20
Source: https://freedombunker.com/2025/10/30/carvana-shares-plunge-nearly-10-despite-strong-headline-earnings/
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
LION'S MANE PRODUCT
Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules
Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.
Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.


